Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials

A Schmitt, L Nguyen, G Zorza, P Ferré… - British journal of …, 2018 - Wiley Online Library
… semiphysiological model) after vinflunine administration show a … renal impaired patients, the
risk is 42.1% when vinflunine is … intravenous vinflunine that may help drive dose adjustment. …

[HTML][HTML] Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an …

M De Santis, PJ Wiechno, J Bellmunt, C Lucas… - … of Oncology, 2016 - Elsevier
… the disease control rate (DCR). This was defined by complete response (CR) + partial response
(PR) + stable disease (SD) for both vinflunine-… patients with PS2 and/or renal impairment

[HTML][HTML] VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis

S Nicholson, H Tovey, T Elliott, SM Burnett… - … Journal of Cancer, 2022 - nature.com
… 0.9% or glucose 5%) via intravenous infusion over 20 min. … The Modification of Diet in Renal
Disease (MDRD) formula … emptive management of constipation are required for vinflunine to …

[HTML][HTML] … treatment patterns, clinical characteristics and survival outcomes for first-and second-line treatment in locally advanced and metastatic urothelial cancer …

G Niegisch, H Gerullis, SW Lin, J Pavlova… - … of Cancer, 2018 - ncbi.nlm.nih.gov
Patients with or without renal impairment had a 12-month OS … 63% among patients with
an Eastern Cooperative Oncology … to compare outcomes in patients receiving vinflunine with …

Vinflunine for the treatment of non-small cell lung cancer

C Genova, A Alama, S Coco, E Rijavec… - Expert Opinion on …, 2016 - Taylor & Francis
… is commonly administered as a 20-minute intravenous (IV) … 33 patients with renal impairment
received IV vinflunine with … to cytotoxic regimens, might achieve disease control with a more …

Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience

H Gerullis, F Wawroschek… - … advances in urology, 2017 - journals.sagepub.com
… schedule for VFL is an intravenous infusion of 320 mg/m 2 … Performance Score, past irradiation,
renal impairment or age >… VFL application in patients with disease control after first-line …

[HTML][HTML] Vincristine-induced peripheral neuropathy (VIPN) in pediatric tumors: mechanisms, risk factors, strategies of prevention and treatment

S Triarico, A Romano, G Attinà, MA Capozza… - International journal of …, 2021 - mdpi.com
… , vinorelbine, vindesine and vinflunine) are a class of … intravenously as vincristine sulfate,
which is a vesicant. After … guidelines for the management of VIPN in this setting of patients, and …

16 Conventional Chemotherapy

BEN Sprangers, L COSMAI… - Onco-Nephrology E-Book, 2019 - books.google.com
… are recommended in patients with renal dysfunction. … is administered intravenously or
intrathecal for the treatment/… newer compound of this family, vinflunine. The only reported adverse …

Evolving treatment of advanced urothelial cancer

SS Sridhar - Journal of Oncology Practice, 2017 - ascopubs.org
… care in the management of urothelial cancer and highlight recent … , and strategies such as
intravenous (IV) hydration or … against best supportive care was vinflunine, which showed an …

Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC

K Pal, VS Madamsetty, SK Dutta… - International journal of …, 2019 - Taylor & Francis
… both three times a week via intravenous route. The liposome … the most effective treatment
group and vehicle control in 786-… vinflunine have been tested in several clinical trials including …